Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
205.66B
Market cap205.66B
Price-Earnings ratio
10.80
Price-Earnings ratio10.80
Dividend yield
2.67%
Dividend yield2.67%
Average volume
20.19M
Average volume20.19M
High today
$47.75
High today$47.75
Low today
$46.26
Low today$46.26
Open price
$46.71
Open price$46.71
Volume
17.85M
Volume17.85M
52 Week high
$81.44
52 Week high$81.44
52 Week low
$35.12
52 Week low$35.12

NVO News

The Motley Fool 5h
Hims HIMS Q1 2026 Earnings Call Transcript

Image source: The Motley Fool. Monday, May 11, 2026 at 5 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Andrew Dudum Chief Financial Officer — Yemi Okupe...

Hims HIMS Q1 2026 Earnings Call Transcript
TipRanks 7h
HIMS Earnings: Hims & Hers Stock Falls 10% as Financial Results Miss Wall Street Targets

The stock of Hims & Hers Health (HIMS) fell as much as 10% in after-hours trading as the telehealth company reported financial results that missed Wall Street t...

Sherwood News 7h
Hims reports revenue miss and surprise loss in Q1

Novo Nordisk products available on Hims & Hers. (Hims & Hers) Hims & Hers fell in after-hours trading after it reported earnings results that missed Wall Stree...

Hims reports revenue miss and surprise loss in Q1

Analyst ratings

60%

of 35 ratings
Buy
31.4%
Hold
60%
Sell
8.6%

More NVO News

TipRanks 16h
Why Eli Lilly’s Rival Novo Nordisk Stock Is Rising Today, 5/11/26

Shares in Novo Nordisk (NVO), the Danish pharma rival to U.S.-based Eli Lilly (LLY), rose roughly 3% in Monday’s pre-market trading. This comes as the Wegovy we...

Simply Wall St 2d
Amazon Pharmacy Deal Puts Novo Nordisk Access And Valuation In Focus

Amazon Pharmacy is expanding patient access to Novo Nordisk’s oral Ozempic for type 2 diabetes through new digital and retail channels. The rollout introduces...

Amazon Pharmacy Deal Puts Novo Nordisk Access And Valuation In Focus
Simply Wall St 2d
Eli Lilly Weighs Foundayo Safety And Capacity As Oral GLP-1 Battle Builds

Eli Lilly's oral obesity drug Foundayo has treated over 20,000 patients in its early launch. Novo Nordisk's oral Wegovy has captured 65% of new U.S. prescripti...

Eli Lilly Weighs Foundayo Safety And Capacity As Oral GLP-1 Battle Builds
Nasdaq 3d
Is This News From Novo Nordisk a Warning for Eli Lilly Shareholders?

Key Points Eli Lilly and Novo Nordisk dominate the weight loss drug market with their injectable GLP-1 drugs. Both players recently won approval for oral form...

Is This News From Novo Nordisk a Warning for Eli Lilly Shareholders?
The Motley Fool 4d
Scholar Rock Q1 2026 Earnings Transcript

Image source: The Motley Fool. Thursday, May 7, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Chief Executive Officer — David Hallal President — Akshay Vaishnaw Chie...

Scholar Rock Q1 2026 Earnings Transcript
TipRanks 4d
Novo Nordisk Sees 40% Spike in India April Sales Despite Generic GLP-1 Rivalry

Danish drugmaker Novo Nordisk (NVO) saw a 40% jump in the sales of its diabetes and weight-loss drugs in April in India, despite intense competition from generi...

TipRanks 4d
Mixed options sentiment in Novo Nordisk with shareslittle changed

Mixed options sentiment in Novo Nordisk (NVO), with shares up 4c, or 0.1%, near $45.80. Options volume relatively light with 69k contracts traded and calls lead...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.